Related Experiment Video

Updated: Jun 17, 2026

Measurement of Heme Synthesis Levels in Mammalian Cells
09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

Metalloporphyrins in the management of neonatal hyperbilirubinemia

David K Stevenson1, Ronald J Wong

  • 1Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA 94304, USA. dstevenson@stanford.edu

Seminars in Fetal & Neonatal Medicine
|December 17, 2009
PubMed

Insights

Neonatal jaundice, a common newborn issue, involves bilirubin buildup. Metalloporphyrins offer a novel approach by inhibiting bilirubin production, potentially preventing severe hyperbilirubinemia.

Area of Science:

  • Biochemistry
  • Neonatology
  • Pharmacology

Background:

  • Neonatal jaundice is a frequent condition in newborns, caused by bilirubin metabolism imbalance.
  • Elevated bilirubin levels (hyperbilirubinemia) can lead to serious neurologic complications.
  • Current treatments like phototherapy and exchange transfusion address existing bilirubin but do not prevent its overproduction.

Purpose of the Study:

  • To explore the potential of metalloporphyrins as a novel therapeutic strategy for neonatal hyperbilirubinemia.
  • To investigate the mechanism of metalloporphyrins in inhibiting bilirubin production.

Main Methods:

  • Review of existing literature on bilirubin metabolism and heme oxygenase.
  • Analysis of studies on synthetic heme analogs (metalloporphyrins) and their inhibitory effects.
  • Evaluation of the proposed application of metalloporphyrins in preventing neonatal hyperbilirubinemia.

Main Results:

  • Heme oxygenase is the rate-limiting enzyme in bilirubin production.
  • Metalloporphyrins act as competitive inhibitors of heme oxygenase.
  • This inhibition reduces the overall production of bilirubin.

Conclusions:

  • Preventing excess bilirubin production is a logical therapeutic goal.
  • Metalloporphyrins represent a promising alternative strategy for managing neonatal hyperbilirubinemia.
  • Further research is warranted to establish the safety and efficacy of metalloporphyrins in clinical settings.

More Related Videos

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice07:48

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice

Published on: October 13, 2018

Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry10:06

Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry

Published on: March 24, 2023

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...